Related Experiment Video
Updated: Dec 30, 2025

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
24.1K
Quantifying Long QT Syndrome in Obese Sleep Apnea Patients Undergoing Roux-en-Y Gastric Bypass Surgery
Summary
Roux-en-Y Gastric Bypass (RYGB) surgery aids weight loss and reduces Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) symptoms. However, apneic patients may retain non-reversible Long QT Syndrome (LQTS) even after significant weight reduction.
Area of Science:
- Cardiology
- Sleep Medicine
- Bariatric Surgery
Background:
- Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) is linked to obesity and Long QT Syndrome (LQTS).
- Weight reduction surgery, like Roux-en-Y Gastric Bypass (RYGB), has shown promise in improving LQTS and OSAHS symptoms in obese patients.
- The long-term impact of RYGB on LQTS in OSAHS patients requires further investigation.
Purpose of the Study:
- To evaluate changes in QT and QTc intervals in obese OSAHS patients following RYGB surgery and weight reduction.
- To compare these changes with a control group of non-apneic individuals who underwent the same procedure.
- To assess the reversibility of LQTS in OSAHS patients after significant weight loss.
Main Methods:
- Development of an algorithm to detect ECG waveforms and calculate QT and QTc intervals.
- Pre- and post-operative ECG measurements were taken for four obese OSAHS patients and three non-apneic controls.
- Comparison of QT and QTc intervals between the groups before and after RYGB surgery.
Main Results:
- RYGB surgery resulted in significant weight loss and reduction in OSAHS symptoms for all participants.
- Obese OSAHS patients showed persistent, potentially non-reversible, LQTS despite substantial weight reduction post-RYGB.
- Control subjects also experienced weight loss and improvements, but their baseline QT/QTc intervals were not detailed in relation to LQTS.
Conclusions:
- RYGB surgery is effective for weight management and alleviating OSAHS symptoms.
- Obese patients with OSAHS may experience non-reversible Long QT Syndrome, even after successful bariatric surgery and weight loss.
- Further research is needed to understand the long-term cardiac implications for OSAHS patients post-RYGB.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
190
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
190
Drug Dosing: Obese Patients
168
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
168
Sleep Apnea
413
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
413

